The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Geographic Variation of p53 Mutational Profile in Nonmalignant Human Liver
Abstract
Fifty-eight percent of hepatocellular carcinomas (HCCs) from Qidong, China, contain an AGG to AGT mutation at codon 249 of the p53 tumor suppressor gene, a mutation that is rarely seen in HCCs from Western countries. The population of Qidong is exposed to high levels of aflatoxin B 1 (AFB 1 ), a fungal toxin that has been shown to induce the same mutation in cultured human HCC cells. To investigate the role of AFB 1 and of these p53 mutations in hepatocarcinogenesis, normal liver samples from the United States, Thailand, and Qidong (where AFB 1 exposures are negligible, low, and high, respectively) were examined for p53 mutations. The frequency of the AGG to AGT mutation at codon 249 paralleled the level of AFB 1 exposure, which supports the hypothesis that this toxin has a causative—and probably early—role in hepatocarcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Self-citationSelective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., & Vogelstein, B. (1990) · PubMed · Cited by 1,063
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
Wood, M. L., Dizdaroglu, M., Gajewski, E., & Essigmann, J. M. (1990) · Biochemistry · doi:10.1021/bi00482a011 · Cited by 683
Aguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
Self-citationp53 mutation in hepatocellular carcinoma after aflatoxin exposure
Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92236-u · Cited by 449
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami, Y., Hayashi, K., Hirohashi, S., & Sekiya, T. (1991) · PubMed · Cited by 374
Lehman, T. A., Bennett, W. P., Metcalf, R. A., Welsh, J. A., Ecker, J., Modali, R. V., Ullrich, S. J., Romano, J. W., Appella, E., & Testa, J. R. (1991) · PubMed · Cited by 373
Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei
Van Rensburg, S. J., Cook-Mozaffari, P., Van Schalkwyk, D. J., Van der Watt, J. J., Vincent, T. J., & Purchase, I. F. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.107 · Cited by 330
[Epidemiology of hepatocellular carcinoma].
Rosellini, S. R., & Miglio, F. (1991) · PubMed · Cited by 326
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China
Yeh, F.-S., Yu, M. C., Mo, C.-C., Luo, S., Tong, M. J., & Henderson, B. E. (1990) · Health Policy · doi:10.1016/0168-8510(90)90389-u · Cited by 324
Moriya, M., Ou, C., Bodepudi, V., Johnson, F., Takeshita, M., & Grollman, A. P. (1991) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(91)90067-y · Cited by 309
p53 gene mutation spectrum in hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 250
Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 164
Scorsone, K. A., Zhou, Y. Z., Butel, J. S., & Slagle, B. L. (1992) · PubMed · Cited by 162
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., & Ishizaki, K. (1993) · PubMed · Cited by 151
Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R., & Sugimachi, K. (1993) · PubMed · Cited by 123
Analysis of the P53 Tumor–Suppressor Gene in Hepatocellular Carcinomas From Britain
Challen, C., Lunec, J., Warren, W., Collier, J. D., & Bassendine, M. F. (1992) · Hepatology · doi:10.1002/hep.1840160610 · Cited by 98
Genotypic mutation analysis by RFLP/PCR
Pourzand, C., & Cerutti, P. (1993) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(93)90213-y · Cited by 92
Self-citationp53 Mutations in human hepatocellular carcinomas from Germany.
Kress, S., Jahn, U.-R., Buchmann, A., Bannasch, P., & Schwarz, M. (1992) · PubMed · Cited by 88
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono, S., Chou, M. J., Lee, C., et al. (1993) · PubMed · Cited by 68
A genotypic mutation system measuring mutations in restriction recognition sequences
Felley‐Bosco, E., Pourzand, C., Zijlstra, J., Amstad, P., & Cerutti, P. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.11.2913 · Cited by 59
Self-citationHirota, H., Kubota, M., Hashimoto, H., Adachi, S., Matsubara, K., Kuwakado, K., Akiyama, Y., Tsutsui, T., & Mikawa, H. (1993) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(93)90069-p · Cited by 28
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690
Self-citationMolecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Metadata
- Authors
- Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., & Cerutti, P.
- Venue
- Science
- Published
- 1994-05-27
- Volume
- 264
- Issue
- 5163
- Pages
- 1317-1319
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2034349902
- Cited by
- 282
- References
- 27
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.